# Dose Finding Study of Single Dose GHB11L1 in Healthy Adults

> **NCT01078701** · PHASE2 · COMPLETED · sponsor: **AVIR Green Hills Biotechnology AG** · enrollment: 49 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** GHB11L1
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01078701
- **Lead sponsor:** AVIR Green Hills Biotechnology AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2011-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078701, "Dose Finding Study of Single Dose GHB11L1 in Healthy Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01078701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*